The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries (English)
Free access
- New search for: Howard, N.
- New search for: Mounier-Jack, S.
- New search for: Gallagher, K. E.
- New search for: Kabakama, S.
- New search for: Griffiths, U. K.
- New search for: Feletto, M.
- New search for: LaMontagne, D. S.
- New search for: Burchett, H. E. D.
- New search for: Watson-Jones, D.
- New search for: Howard, N.
- New search for: Mounier-Jack, S.
- New search for: Gallagher, K. E.
- New search for: Kabakama, S.
- New search for: Griffiths, U. K.
- New search for: Feletto, M.
- New search for: LaMontagne, D. S.
- New search for: Burchett, H. E. D.
- New search for: Watson-Jones, D.
In:
Human Vaccines & Immunotherapeutics
;
12
, 9
;
2475-2477
;
2016
- Article (Journal) / Electronic Resource
-
Title:The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries
-
Contributors:Howard, N. ( author ) / Mounier-Jack, S. ( author ) / Gallagher, K. E. ( author ) / Kabakama, S. ( author ) / Griffiths, U. K. ( author ) / Feletto, M. ( author ) / LaMontagne, D. S. ( author ) / Burchett, H. E. D. ( author ) / Watson-Jones, D. ( author )
-
Published in:Human Vaccines & Immunotherapeutics ; 12, 9 ; 2475-2477
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2016-09-01
-
Size:3 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 12, Issue 9
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2215
-
Letter from the editor| 2016
- 2216
-
Human Vaccines & Immunotherapeutics: News| 2016
- 2219
-
Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancersRajan, Arun / Kim, Chul / Heery, Christopher R. / Guha, Udayan / Gulley, James L. et al. | 2016
- 2232
-
Dendritic cell vaccines: A review of recent developments and their potential pediatric applicationElster, Jennifer D. / Krishnadas, Deepa K. / Lucas, Kenneth G. et al. | 2016
- 2240
-
Chronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodiesHambuchen, Michael D. / Rüedi-Bettschen, Daniela / Gunnell, Melinda G. / Hendrickson, Howard / Owens, S. Michael et al. | 2016
- 2249
-
Immunoregulatory pathways following strong inflammatory processes markedly impair CD4+ T cell responsesMinnar, Christine M. / Murphy, William J. et al. | 2016
- 2253
-
Heparanase and cancer progression: New directions, new promisesArvatz, Gil / Weissmann, Marina / Ilan, Neta / Vlodavsky, Israel et al. | 2016
- 2257
-
MYCN-targeting vaccines and immunotherapeuticsSchramm, Alexander / Lode, Holger et al. | 2016
- 2259
-
Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in EuropeUhart, Mathieu / Bricout, Hélène / Clay, Emilie / Largeron, Nathalie et al. | 2016
- 2269
-
Cost–effectiveness analysis of quadrivalent influenza vaccine in SpainGarcía, Amos / Ortiz de Lejarazu, Raúl / Reina, Jordi / Callejo, Daniel / Cuervo, Jesús / Morano Larragueta, Raúl et al. | 2016
- 2278
-
Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority studyBart, Stephan / Cannon, Kevin / Herrington, Darrell / Mills, Richard / Forleo-Neto, Eduardo / Lindert, Kelly / Abdul Mateen, Ahmed et al. | 2016
- 2289
-
Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™Canelle, Quentin / Dewé, Walthère / Innis, Bruce L. / van der Most, Robbert et al. | 2016
- 2299
-
Economic evaluation of HBV vaccination: A systematic review of recent publications (2000–2013)La Torre, Giuseppe / Mannocci, Alice / Saulle, Rosella / Colamesta, Vittoria / Meggiolaro, Angela / Mipatrini, Daniele / Sinopoli, Alessandra et al. | 2016
- 2312
-
Comparison of the effect of increased hepatitis B vaccine dosage on immunogenicity in healthy children and adultsKang, Guodong / Chen, Haiping / Ma, Fubao / Yang, Yunkai / Wang, Zhiguo / Guo, Shaohong / Song, Jiping et al. | 2016
- 2317
-
Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patientsVilajeliu, Alba / Sequera, Víctor-Guillermo / García-Basteiro, Alberto L. / Sicuri, Elisa / Aldea, Marta / Velasco, César / Bayas, José M. et al. | 2016
- 2322
-
Comparison of immune persistence among inactivated and live attenuated hepatitis a vaccines 2 years after a single doseZhang, Xiaoshu / An, Jing / Tu, Aixia / Liang, Xuefeng / Cui, Fuqiang / Zheng, Hui / Tang, Yu / Liu, Jianfeng / Wang, Xuxia / Zhang, Ningjing et al. | 2016
- 2327
-
Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infectionLauretti, Flavio / Chattopadhyay, Anasuya / de Oliveira França, Rafael Freitas / Castro-Jorge, Luiza / Rose, John / Fonseca, Benedito A. L. da et al. | 2016
- 2334
-
Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trialChu, Kai / Hu, Jialei / Meng, Fanyue / Li, Jingxin / Luo, Li / Xu, Jianjun / Yuan, Zhonghang / Li, Zhiyong / Chen, Wangeng / Jiao, Lei et al. | 2016
- 2341
-
Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatisVisan, Lucian / Sanchez, Violette / Kania, Margaux / de Montfort, Aymeric / de la Maza, Luis M. / Ausar, Salvador Fernando et al. | 2016
- 2351
-
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virusAgrawal, Anurodh Shankar / Tao, Xinrong / Algaissi, Abdullah / Garron, Tania / Narayanan, Krishna / Peng, Bi-Hung / Couch, Robert B. / Tseng, Chien-Te K. et al. | 2016
- 2357
-
Why we need a vaccine for non-typeable Haemophilus influenzaeCerquetti, Marina / Giufrè, Maria et al. | 2016
- 2362
-
Salmonella flagellin acted as an effective fusion partner for expression of Plasmodium falciparum surface protein 25 in Escherichia coliQian, Feng / Li, Mengmeng / Chen, Yong / Jiang, Lin / Xu, Huji et al. | 2016
- 2365
-
Issues in pediatric vaccine-preventable diseases in low- to middle-income countriesDbaibo, Ghassan / Tatochenko, Vladimir / Wutzler, Peter et al. | 2016
- 2378
-
Cost-effectiveness of a herpes zoster vaccination program among the French elderly peopleBelchior, Emmanuel / Lévy-Bruhl, Daniel / Le Strat, Yann / Herida, Magid et al. | 2016
- 2383
-
Clinical and economic impact of a specific BCG vaccination program implemented in Prato, central Italy, involving foreign newborns on hospitalizationsBellini, Irene / Nastasi, Antonino / Boccalini, Sara et al. | 2016
- 2391
-
Effect of antipyretic analgesics on immune responses to vaccinationSaleh, Ezzeldin / Moody, M. Anthony / Walter, Emmanuel B. et al. | 2016
- 2403
-
Post-GAVI sustainability of the Haemophilus influenzae type b vaccine program: The potential role of economic evaluationLe, Phuc / Nghiem, Van T. / Swint, J. Michael et al. | 2016
- 2406
-
Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccinationSteele, A. Duncan / Madhi, Shabir A. / Cunliffe, Nigel A. / Vesikari, Timo / Phua, Kong Boo / Lim, Fong Seng / Nelson, E. Anthony S. / Lau, Yu-Lung / Huang, Li-Min / Karkada, Naveen et al. | 2016
- 2413
-
Nosocomial rotavirus infection: An up to date evaluation of European studiesGervasi, G. / Capanna, A. / Mita, V. / Zaratti, L. / Franco, E. et al. | 2016
- 2419
-
Post-rotavirus vaccine intussusception in identical twins: A case reportLa Rosa, F. / Scuderi, M. G. / Taranto, V. / La Rosa, V. / Spinello, C. M. / La Camera, G. / Astuto, M. et al. | 2016
- 2422
-
Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature reviewDeAntonio, Rodrigo / Yarzabal, Juan-Pablo / Cruz, James Philip / Schmidt, Johannes E. / Kleijnen, Jos et al. | 2016
- 2441
-
Nasopharyngeal pneumococcal carriage rates among HIV-infected adults following widespread pediatric use of conjugate pneumococcal vaccine-13Feola, Theresa D. / Bonville, Cynthia A. / Cibula, Donald A. / Jose, Sherly / Nattanmai, Geetha / Domachowske, Joseph B. / Suryadevara, Manika et al. | 2016
- 2447
-
Intradermal vaccination for infants and childrenSaitoh, Akihiko / Aizawa, Yuta et al. | 2016
- 2456
-
Mucosal adjuvants: Opportunities and challengesZeng, Lingbin et al. | 2016
- 2459
-
Knowledge, risk perception and attitudes toward vaccination among Austrian health care workers: A cross-sectional studyHarrison, Nicole / Brand, Alexandra / Forstner, Christina / Tobudic, Selma / Burgmann, Karin / Burgmann, Heinz et al. | 2016
- 2464
-
Vaccine hesitancy: More than a movementCallender, David et al. | 2016
- 2469
-
Are good intentions putting the vaccination ecosystem at risk?Watson, Michael / Faron de Goër, Eliot et al. | 2016
- 2475
-
The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countriesHoward, N. / Mounier-Jack, S. / Gallagher, K. E. / Kabakama, S. / Griffiths, U. K. / Feletto, M. / LaMontagne, D. S. / Burchett, H. E. D. / Watson-Jones, D. et al. | 2016
- 2478
-
Corrigendum| 2016